Medical device company Stryker has signed a definitive agreement to acquire privately held Gaymar Industries for approximately USD150m in an all-cash transaction.
Gaymar specialises in support surface and pressure ulcer management solutions as well as the temperature management segment of the healthcare industry.
The transaction, which is expected to close by 1 October 2010, is conditioned on expiration or termination of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and other customary closing conditions.
The boards of directors of both Stryker and Gaymar Industries have approved the transaction.
Gaymar Industries was founded in 1956 and has been owned by private equity firms Nautic Partners and Norwest Equity Partners since 2003. Stryker’s medical division and Gaymar have had a ten-year original equipment manufacturer relationship whereby Gaymar has been providing Stryker with exclusive rights to sell support surface and pressure ulcer management products to acute care customers in North America.
The acquisition expands Stryker’s product offerings in the high-performance support surface and pressure ulcer management market, while also providing a complementary product offering to its existing customer base through its temperature management technology platform.
Gaymar achieved sales of approximately USD77m in 2009, of which approximately USD14m were related to the existing OEM relationship with Stryker.
"The acquisition of Gaymar Industries is consistent with our strategic goal of expanding our existing product offering and extensive sales force presence via innovative and value added products," says Stephen P. MacMillan, chairman, president and chief executive officer of Stryker. "In addition to a talented team, Gaymar provides our medical division with an attractive portfolio of high-performance support surface and pressure ulcer management products that target an approximately USD1.8bn worldwide market, while simultaneously enhancing our customer relationships through the addition of their temperature management offering."
"We are thrilled to become part of Stryker and broaden the availability of our clinically proven products," adds Kent Davies, chief executive of Gaymar. "The integration of our complementary product portfolio will strengthen Stryker’s leadership in patient handling while driving innovations that can help prevent adverse events and reduce healthcare costs. Through Stryker, we will provide more opportunities to our employees, our customers and the patients that we serve."
Upon closing, the transaction is expected to be neutral to Stryker’s 2010 and 2011 earnings per share and accretive thereafter.